Pasithea Therapeutics (KTTA) Total Liabilities (2020 - 2026)

Pasithea Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 8.2% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 8.2% YoY), while the FY2025 annual figure was $5.0 million, up 291.63% from the prior year.
• Total Liabilities came in at $1.5 million for Q1 2026 at Pasithea Therapeutics, down from $5.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $5.0 million in Q4 2025 to a low of $823975.0 in Q3 2024.
• A 5-year average of $2.1 million and a median of $1.8 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 430.62% in 2022 and sank 63.92% in 2024, its largest moves.
• Pasithea Therapeutics' Total Liabilities stood at $2.7 million in 2022, then climbed by 1.36% to $2.7 million in 2023, then plunged by 52.84% to $1.3 million in 2024, then surged by 291.63% to $5.0 million in 2025, then sank by 69.28% to $1.5 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.5 million, $5.0 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison